Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alstrom syndrome protein 1 (ALMS1) is a large centrosome/basal body-associated protein encoded by the ALMS1 gene on chromosome 2p13. It plays key roles likely related to microtubule organization during cell division and intracellular trafficking—including receptor recycling—and may be critical for normal ciliary structure/function across multiple organ systems. Loss-of-function mutations lead directly or indirectly to multisystem disease manifestations seen in Alström syndrome—including obesity/type II diabetes/blindness/hearing loss/fibrosis—with emerging evidence supporting its relevance as a therapeutic target beyond rare genetic disease contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alstrom Syndrome Protein 1 (ALMS1).